| INTRODUCTION
Nearly one half of American adults have hypertension. 1 Despite this prevalence, control rates nationally are poor at only around 50%, even using a lenient criterion for hypertension: blood pressure (BP) ≥ 140/90 mm Hg. 2 In addition to substantially increased risk of cardiovascular disease, uncontrolled hypertension generates an enormous burden on healthcare systems. Traditional office-based management of high BP is inefficient and often ineffective.
Selected healthcare systems have reached hypertension control rates of 80% to 90%, their success relying upon suitable organizational and financial structures. 3 Team-based care models focused on telemonitoring report varying degrees of success. [4] [5] [6] [7] [8] [9] We developed and piloted a system for BP control using entirely remote "visits" with BWH hypertension specialists from the divisions of Cardiovascular Medicine and Endocrinology, Diabetes and Hypertension developed a clinical algorithm, which is based upon NICE and ACC/AHA guidelines 1, 12 and emphasizes simplicity, efficacy, and once-daily generic medications, strategies proven to improve medication adherence [ Figure 1 ]. Pharmacists in primary care and cardiology reviewed, provided feedback, and advanced the algorithm to approval through multidisciplinary review at the BWH Pharmacy and Therapeutics
Committee. Once stable medication doses are reached and BP is controlled, the algorithm dictates that patients are prescribed combination pills if possible, a technique proven to improve adherence. 13 To maximize adherence by limiting pill burden, hydrochlorothiazide is the initial diuretic rather than chlorthalidone or indapamide, because of the near-universal availability of combination drugs with hydrochlorothiazide but not other diuretics. To avoid the common side effect of This program enables more frequent dose adjustments of medications than usual. After each titration, patients wait 1 week for stabilization, and then repeat a set of home BP measurements for 1 week.
Thus, the cycle of medication titrations occurs every 2 weeks. This frequency is in accord with the physiology of the BP agents we employ: ACE inhibitors, angiotensin-receptor blockers, calcium channel blockers, and diuretics all have peak effect within a few days to a week. A meta-analysis has shown that estimation of maximal effect 
| RESULTS
The average age of enrolled patients was 59 years; 56% were female and 61% white ( DBP was significantly higher in non-diabetics compared to patients with diabetes (P = 0.03; Table 2 ).
Of the 130 total enrolled patients, control was reached in 81%.
Eleven patients dropped out, in most instances because of insufficient engagement. Three had resistant hypertension and were referred to specialty care; 116 remained in the program. Ten patients were identified with white coat hypertension with normal home BP in their first week of outpatient measures.
Of those 116 who were engaged in the program and measured their BP at home, 91% reached goal home BP, in an average of 7 ± 7 weeks.
SBP in these 105 patients fell from baseline clinic pressure 155 ± 18 to 124 ± 8 mm Hg average home BP upon graduation. DBP fell from 92 ± 13 to 74 ± 8 mm Hg; (P < 0.0001 for both; Figure 2 ).
Control was reached without a large increase in pill burden: the average number of medications from baseline to control increased from 1.4 to 1.8. Amlodipine was the most common new drug added. Diabetes mellitus (n) 25
Creatinine baseline mg/dl 0.96 + 0.5
Potassium baseline mEq/L 4.2 + 0.4 (Table 2) . DBP was significantly lower among older vs younger patients both at baseline and study conclusion, and similarly lower among patients with diabetes vs non-diabetics; ( Table 2) .
Follow-up clinic blood pressures within 1 year were obtained in 99 participants, at an average of 7 months past graduation. These patients were no longer in regular contact with program staff, and were no longer receiving regular reminders to measure blood pressure at home, or guidance about medications or lifestyle. Comparing clinic pressures from enrollment to follow-up in this subset, SBP fell from 157 ± 18 to 139 ± 22, and DBP from 87 ± 13 to 75 ± 11 mm Hg (P < 0.0001 for both).
| DISCUSSION
We describe a new care-delivery paradigm aimed to improve hypertension control rates quickly and at significantly lower cost than traditional office-based BP programs. This remote BP management program addresses several limitations of the current care system, including poor patient identification, therapeutic inertia, significant delays in medication titration, and lack of patient engagement or involvement. Its novelty lies in several main domains. First, the program is built to be run by patient navigators, not by medical doctors or other licensed health care professionals. Second, the reason navigators are able to administer the program is that medication titrations follow a computerized algorithm, developed by hypertension specialists. Third, the program has a quick time course for medication titration built in, resulting in rapid control of hypertension. And fourth, it employs a highly developed, integrated set of technological and computer elements to facilitate the automated transmission of home pressures and calculations of average weekly blood pressures directly into the medical record and into the operating software.
Control was reached in 81% overall, and in 91% of those who were engaged in the program and measured their home BP. Control was reached quickly, in an average of 7 weeks, and without a large increase in pill burden, implying that much of the benefit in BP was achieved through improved adherence and maximizing drug choice and doses. The algorithm is designed to increase adherence not just in the short term, while patients are receiving frequent feedback from navigators, but it also aims to promote sustained, long-term medication adherence. Features to maximize adherence include: selecting drugs that are generic and hence lowest cost; using once daily medications and combination drugs to minimize total pill burden; and choosing drugs that are likely to have greatest impact in reducing blood pressure.
As evidence of efficacy, follow-up blood pressures in the clinic at an average of 7 months showed significant, sustained reductions in pressure. These lower pressures persisted even after patients "graduated" from the program upon reaching home blood pressure < 135/85 mm Hg, and no longer had frequent communications from navigators including reminders to measure blood pressure at home, guidance about medications, and lifestyle coaching.
The success rate is similar to that of Kaiser Permanente Northern California, who developed a process for large-scale control of hypertension. 3 In addition to differences in the clinical algorithm (all patients at Kaiser are started on an ACE inhibitor/thiazide combination pill), Our pilot study is limited by small size, the absence of a control group, and the lack of any long-term clinical outcome data. Not all patients continued to monitor their home BP measurements, reflecting in many cases a lack of understanding and engagement.
| Challenges and lessons learned
Challenges occurred at every step of program development. Understanding and solving problems encountered has been critical to refining the implementation of the integrated program and adopting it for application on a much larger scale.
There are multiple key factors contributing to successful control of hypertension in a large-scale program, and these factors mandate coordinated teamwork spanning all tiers of the healthcare system. In order to achieve high rates of control, we need to engage patients maximally, making best use of patient-facing educational tools. Patient navigators are ideal to serve as motivators and coaches in addition to their role in managing therapy; they provide constancy, personalized education and motivational support in addition to medication titrations. 24 Our navigators interview patients regarding relevant health habits at the outset, to direct individualized counseling on lifestyle modifications. Education focuses on weight loss, physical activity, and sodium and alcohol consumption.
Patients are able to contact navigators with any questions or concerns.
Using non-licensed patient navigators to provide the majority of patient interactions also reduces the burden on physicians, NPs or pharmacists in day-to-day BP management; thus, differentiating this program from most other telemonitoring programs and creating a model for sustainable scalability. 
